Memorial Sloan Kettering Cancer Center Oric Pharmaceuticals, Inc. Transaction History
Memorial Sloan Kettering Cancer Center
- $24.6 Million
- Q3 2023
A detailed history of Memorial Sloan Kettering Cancer Center transactions in Oric Pharmaceuticals, Inc. stock. As of the latest transaction made, Memorial Sloan Kettering Cancer Center holds 602,272 shares of ORIC stock, worth $4.86 Million. This represents 14.83% of its overall portfolio holdings.
Number of Shares
602,272
Previous 602,272
-0.0%
Holding current value
$4.86 Million
Previous $4.67 Million
22.04%
% of portfolio
14.83%
Previous 14.75%
Shares
1 transactions
Others Institutions Holding ORIC
# of Institutions
124Shares Held
66.6MCall Options Held
7.8KPut Options Held
700-
Nextech Invest Ag5.29MShares$42.7 Million8.84% of portfolio
-
Black Rock Inc. New York, NY4.83MShares$39 Million0.0% of portfolio
-
Vr Adviser, LLC New York, NY4.39MShares$35.5 Million4.67% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA4.14MShares$33.4 Million2.29% of portfolio
-
Viking Global Investors LP4MShares$32.3 Million0.16% of portfolio
About Oric Pharmaceuticals, Inc.
- Ticker ORIC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,576,700
- Market Cap $319M
- Description
- ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...